Effects of candidate vaginally-applied microbicide compounds on innate immune cells

Journal of Reproductive Immunology

Volumn 66, Issue 2, 2005, Pages 103-116

  Milligan, Gregg N ^a   Young, Christal G ^a   Meador, Michael G ^a   Chu, Chin Fun ^a   Stanberry, Lawrence R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Macrophage; Phagocytosis; Sexually transmitted disease; Topical microbicide; Vagina

Indexed keywords

ANTIINFECTIVE AGENT; CARRAGEENAN; CD11B ANTIGEN; CD18 ANTIGEN; CHOLIC ACID; DETERGENT; FLUOROCHROME; MEMBRANE PROTEIN; POLYMER; POLYSACCHARIDE; POLYSTYRENESULFONIC ACID; PRO 2000; SULFATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIUM; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL LABELING; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; IMMUNOTOXICITY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; VAGINA; VAGINA EPITHELIUM; VAGINA MUCOSA;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CARRAGEENAN; CHOLIC ACID; DETERGENTS; FEMALE; FLOW CYTOMETRY; IMMUNITY, NATURAL; MACROPHAGES; MICE; MUCOUS MEMBRANE; NAPHTHALENESULFONATES; PHAGOCYTOSIS; POLYMERS; POLYSTYRENES; VAGINA;

EID: 23044451774     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2005.04.003     Document Type: Article

References (34)

1. D. Anderson, and E.J. Yunis Trojan horse leukocytes in AIDS N. Engl. J. Med. 309 1983 984 985
2. M. Baba, D. Schols, H. Nakashima, R. Pauwels, G. Parmentier, D.K. Meijer, and E. De Clercq Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro J. Acquir. Immun. Defic. Syndr. 2 1989 264 271
3. N. Bourne, D.I. Bernstein, J. Ireland, A.F. Sonderfan, A.T. Profy, and L.R. Stanberry The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model J. Infect. Dis. 180 1999 203 205
4. N. Bourne, L.J.D. Zaneveld, J.A. Ward, J.P. Ireland, and L.R. Stanberry Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice Clin. Microbiol. Infect. 9 2003 816 822
5. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res. 47 1987 936 942
6. E. Caron, and A. Hall Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases Science 282 1998 1717 1721
7. B.J. Catalone, T.M. Kish-Catalone, L.R. Budgeon, E.B. Neely, M. Ferguson, F.C. Krebs, M.K. Howett, M. Labib, R. Rando, and B. Wigdahl Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides Antimicrob. Agents Chemother. 48 2004 1837 1847
8. C. Coggins, K. Blanchard, F. Alvarez, V. Brache, E. Wisberg, P.H. Kilmarx, M. Lacarra, R. Massai, D. Mishell Jr., A. Salvatierra, P. Witwatwongwana, C. Elias, and C. Ellertson Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide Sex. Transm. Inf. 76 2000 480 483
9. P. Greenhead, P. Hayes, P.S. Watts, K.G. Laing, G.E. Griffin, and R.J. Shattock Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides J. Virol. 74 2000 5577 5586
10. C.E. Hart, J.L. Lennox, M. Pratt-Palmore, T.C. Wright, R.F. Schinazi, T. Evans Strickfaden, T.J. Bush, C. Schnell, L.J. Conley, K.A. Clancy, and T.V. Ellerbrock Correlation of human immunodeficiency virus type 1 RNA level in blood and the female genital tract J. Infect. Dis. 179 1999 871 882
11. B.C. Herold, R. Kirkpatrick, D. Marcellino, A. Travelstead, V. Pilipenko, H. Krasa, J. Bremer, L.J. Dong, and M.D. Cooper Bile salts: natural detergents for the prevention of sexually transmitted diseases Antimicrob. Agents Chemother. 43 1999 745 751
12. P.J. Hitchcock Topical microbicides L.R. Stanberry D.I. Bernstein Sexually Transmitted Disease Vaccines, Prevention and Control 2000 Academic Press San Diego, CA 149 166
13. T. Izumi, and M. Hirata Complexation of papain with strong polyanions and enzymatic activities of resulting complexes J. Macromol. Sci. Pure Appl. Chem. A31 1994 39 51
14. J.N. Krieger, R.W. Coombs, A.C. Collier, S.O. Ross, K. Chaloupka, D.K. Cummings, V.L. Murphy, and L. Corey Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy J. Infect. Dis. 163 1991 386 388
15. V. Le Cabec, S. Carreno, A. Moisand, C. Bordier, and I. Maridonneau-Parini Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively J. Immunol. 169 2003-2009
16. R.I. Lehrer, A.K. Lichtenstein, and T. Ganz Defensins: antimicrobial and cytotoxic peptides of mammalian cells Annu. Rev. Immunol. 11 1993 105 128
17. K.H. Mayer, S.A. Karim, C. Kelly, L. Maslankowski, H. Rees, A.T. Profy, J. Day, J. Welch, and Z. Rosenberg For the HIV Prevention Trials Network (HPTN) 020 Protocol Team. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women AIDS 17 2003 321 329
18. G.N. Milligan, C.-F. Chu, C.G. Young, and L.R. Stanberry Effect of candidate vaginally-applied microbicide compounds on recognition of antigen by CD4+ and CD8+ T lymphocytes Biol. Reprod. 71 2004 1638 1645
19. G.N. Milligan, K.L. Dudley, N. Bourne, A. Reece, and L.R. Stanberry Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents Sex. Trans. Dis. 29 2002 597 605
20. K. Morrow, R. Rosen, L. Richter, A. Emans, A. Forbes, D. Day, N. Morar, L. Maslankowski, A.T. Profy, C. Kelly, A. Karim, and K.H. Mayer The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial J. Women's Health 12 2003 655 666
21. S. Niruthisard, R.E. Roddy, and S. Chutivongse The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa Sex. Trans. Dis. 18 1991 176 179
22. D.L. Patton, S.S. Thwin, A. Meier, T.M. Hooton, A.E. Stapleton, and D.A. Eschenbach Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle Am. J. Obstet. Gynecol. 183 2000 967 973
23. R. Pearce-Pratt, and D.M. Phillips Sulphated polysaccharides inhibit lymphocyte-to-epithelial transmission of HIV Biol. Reprod. 54 1996 173 182
24. R) containing sodium cholate Hum. Reprod. 8 1993 866 869
25. S. Rusconi, M. Moonis, D.P. Merrill, P.V. Pallai, E.A. Neidhardt, S.K. Singh, K.J. Willis, M.S. Osburne, A.T. Profy, J.C. Jenson, and M.S. Hirsch Napthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities Antimicrob. Agents Chemother. 40 1996 234 236
26. M.E. Selsted, and A.J. Ouellette Defensins in granules of phagocytic and non-phagocytic cells Trends Cell Biol. 5 1995 114 119
27. M.K. Stafford, H. Ward, A. Flanagan, I.J. Rosenstein, D. Taylor-Robinson, J.R. Smith, J. Weber, and V.S. Kitchen Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects J. Acquir. Immun. Defic. Syndr., Hum. Retrovirol. 17 1998 327 331
28. A. Stone Microbicides: a new approach to preventing HIV and other sexually transmitted infections Nat. Rev. Drug Discov. 1 2002 977 985
29. Y. Sugita-Konishi, S. Yamashita, F. Amanoi, and M. Shimizu Effects of carrageenans on the binding, phagocytotic, and killing abilities of macrophages to Salmonella Biosci. Biotechnol. Biochem. 67 2003 1425 1428
30. J.A.F. Van Strijp, D.G. Russel, E. Tuomanen, E.J. Brown, and S.D. Wright Ligand specificity of purified complement receptor type three (CD11b/CD18, αMβ2 Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence J. Immunol. 151 1993 3324 3336
31. World Health Organization WHO/CONRAD technical consultation on nonoxynol-9 Summary Report. Reprod. Health Matters, vol. 10 World Health Organization, Geneva, October 9-10, 2001 2002 175 181
32. S.D. Wright, and T.C. Jong Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide J. Exp. Med. 164 1986 1876 1888
33. V. Zacharapoulos, and D.M. Phillips Vaginal formulations of carrageenan protect mice from herpes simplex virus infection Clin. Diagn. Lab. Immunol. 44 1997 65 468
34. L.J.D. Zanefeld, D.P. Waller, R.A. Anderson, I.I.C. Chany, W.F. Rencher, K. Feathergill, W.-H. Diao, G.F. Doncel, B. Herold, and M. Cooper Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate) Biol. Reprod. 66 2002 886 894